Clinical trial data presented this weekend show drugs from Takeda, Alkermes and Eisai significantly helped people with ...

(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain ...

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered ...

The health agency launched the list of drugs in 1977 to promote better access to medicine in developing countries.

With nitazene use rising around the world, and in particular in Australia and Europe, scientists are scrambling to gather ...

More than 400 vape pods, believed to contain the restricted anaesthetic agent, were seized.

In 22.2% of trials, there was a survival benefit with the next-in-class agent. Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head ...